Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient

Author: Morales Enrique   Morales Rafael   Gutiérrez Eduardo   Rojas-Rivera Jorge   Praga Manuel  

Publisher: Oxford University Press

ISSN: 2048-8505

Source: Clinical Kidney Journal, Vol.5, Iss.6, 2012-12, pp. : 608-609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract